PACB

Pacific Biosciences Of California Stock Analysis

AI Rating

Low
  • Quality1/10
  • Growth↓ 2/10
  • Momentum↑ 5/10
Pacific Biosciences Of California sales and earnings growth
PACB Growth
Fair
  • Revenue Y/Y↓ -10.72%
  • EPS Y/Y↓ -15.75%
  • FCF Y/Y↑ 47.30%
Pacific Biosciences Of California gross and profit margin trends
PACB Profitability
Low
  • Gross margin ↑ 25.40%
  • EPS margin↓ -325.80%
  • ROIC↓ -45.80%
Pacific Biosciences Of California net debt vs free cash flow
PACB Risk
Poor
  • Debt / Equity↑ 19.4
  • Debt / FCF↑ 5.1
  • Interest coverage↓ -62.1

Pacific Biosciences Of California stock volatility is higher than the overall market. We give it a Poor risk rating.

More Medical Devices stocks ↗